TickerFacts.

Femasys Inc (FEMY): Revenue

Annual figures by period end, from SEC filings.

$2.29M
Year ended 2025-12-31
$2.30M
Trailing 12 months to 2026-06-30
+23.9%
3-year compound annual growth
+17.2%
5-year compound annual growth
2020-12-31: $1.04M2021-12-31: $1.18M2022-12-31: $1.21M2023-12-31: $1.07M2024-12-31: $1.63M2025-12-31: $2.29M$2.29M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.29M+40.8%2026-03-31, From 2025-01-01
2024-12-31$1.63M+52.0%2026-03-31, From 2024-01-01
2023-12-31$1.07M-11.1%2025-03-27, From 2023-01-01
2022-12-31$1.21M+2.2%2024-03-28, From 2022-01-01
2021-12-31$1.18M+13.7%2023-07-24, From 2021-01-01
2020-12-31$1.04Mn/a2022-03-24, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Femasys Inc (FEMY)2025-12-31$2.29M+40.8%
QHSLab, Inc. (USAQ)2025-12-31$2.69M+26.3%
Vycor Medical Inc (VYCO)2025-12-31$1.86M+17.2%
OSR Health, Inc. (OSRH)2025-12-31$2.91M-17.7%
EBR Systems, Inc. (NONE.)2025-12-31$1.62Mn/a
Nuo Therapeutics, Inc. (AURX)2025-12-31$3.31M+142.7%
IceCure Medical Ltd. (ICCM)2025-12-31$3.38M+2.7%
Tenon Medical, Inc. (TNON)2025-12-31$3.94M+20.4%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$4.22M+38.1%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗